Some Important Studies from the SCAI Meeting

                The recent virtual 2020 meeting of the Society for Cardiovascular Angiography and Interventions included a great deal of news worthy of expanded coverage in your journal. The highlights include studies describing several trials: TWLIGHT-SYNERGY, the ISCHEMIA trial, and a network that uses telemedicine to organize care for 100 million myocardial infarction patients.

                TWILIGHT-SYNERGY, a study comparing bioabsorbable versus durable polymer everolimus-eluting stents, was described in abstract #11754, “Safety and efficacy of the bioabsorbable polymer everolimus-eluting stent in high-risk patients undergoing PCI: TWILIGHT-SYNERGY,” Baber U, Dangas G, Sharma S, et al.

                ISCHEMIA, a study of more than 5,000 participants with intermediate left main disease undergoing coronary computed tomography angiography, was described in abstract #11656, “Outcomes with Intermediate Left Main Disease on Coronary CT Angiography in the ISCHEMIA trial (ISCHEMIA Intermediate LM Substudy),” Bangalore S., Spertus J., Stevens S).

                The Latin America Telemedicine Network was described in a study authored by Sameer Mehta, MD, et al (‘The Latin America Telemedicine Network & the Public Good’). The network has functioned between 2013 to present in four countries: Brazil, Colombia, Mexico, and Argentina.